Press Releases :: Beyond Air Inc. (XAIR)

Beyond Air® Schedules Fiscal Year 2021 Financial Results Conference Call and Webcast

May 25, 2021 7:30am EDT

Beyond Air® Strengthens Commercial Leadership Team with Appointments of Head of Sales and Head of Marketing

May 20, 2021 8:00am EDT

Beyond Air® Presents Data in Hospitalized Patients with Viral Lung Infections (including COVID-19) from LungFit® PRO Programs at ATS 2021

May 13, 2021 8:00am EDT

Beyond Air® Appoints Peter Senior as Director of Business Development

May 03, 2021 8:00am EDT

Beyond Air® Announces Participation at Upcoming Virtual Investor Conferences in May 2021

Apr 14, 2021 8:00am EDT

Beyond Air® to Present Abstracts at the American Thoracic Society Virtual Sessions in May 2021

Mar 24, 2021 8:00am EDT

Beyond Air® Announces Participation at Upcoming Virtual Investor Conferences in March 2021

Mar 01, 2021 8:00am EST

Beyond Air® Receives Grant for Up to $2.17 million from the Cystic Fibrosis Foundation to Advance the Clinical Development of Inhaled Nitric Oxide to Treat Nontuberculous Mycobacteria Pulmonary Disease

Feb 16, 2021 8:00am EST

Beyond Air® Reports Financial Results for Third Quarter of Fiscal Year 2021 and Provides Business Update

Feb 09, 2021 4:05pm EST

Beyond Air® Schedules Third Fiscal Quarter 2021 Financial Results Conference Call and Webcast

Jan 15, 2021 4:10pm EST

1
2
3
4
5
6
7
8
9
10
...15

Important Safety Information

^†Caution - LungFit is an Investigational Device, Limited by Federal (or United States) Law to Investigational Use.